Allergy Therapeutics to present at H.C. Wainwright Global Investment Conference
Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has announced that company management will participate in a fireside chat at the upcoming H.C. Wainwright Global Investment